Study On Strategic Transition Of FY Pharmaceutical Commercial Company Under The Background Of Two-vote System

Under the background of the new era,the reform of the medical and health system has gradually entered the deep water area.Around the government of the medical and health industry,a series of reform policies have been issued,such as the consistency evaluation of generic drugs in the production registration process,the national centralized procurement in the bidding procurement process,the two vote system in the circulation and distribution process,the key monitoring of auxiliary drugs in the clinical use process,and the medical insurance reimbursement process Government regulation and institutional changes have brought great challenges to the pharmaceutical industry,but also significant development opportunities.The reform of medicine circulation system is the core and entry point of medicine and health system reform.Medicine commercial company is the carrier of medicine circulation.As the intermediate bridge connecting medicine production enterprises and medicine consumption terminal,medicine commercial company plays an important role in medicine circulation field.At present,there are many disadvantages in China’s drug circulation market,such as the confusion of circulation enterprises,the confusion of circulation order,the virtual high price of drugs,the dispersion of market pattern,etc.based on this country’s drug two vote system policy,the aim is to strengthen the whole process supervision and reduce the supervision cost by reducing and limiting the length and width of drug circulation channels,so as to completely block the increase of prices in circulation field As a result,the drug price is falsely high,which makes the drug distribution enterprises develop towards the direction of scale,intensification and intelligence.At the same time,the two vote system policy also has a huge impact on the pharmaceutical commercial companies.First of all,it is reflected in the industry concentration,a large number of small and mediumsized pharmaceutical commercial companies are acquired,merged or eliminated;secondly,the profit model that traditional pharmaceutical commercial companies rely on for survival of commercial allocation and sales,to earn the price difference between import and sales,no longer exists;thirdly,based on the two vote system,supplemented by other pharmaceutical policies It makes the retail price of drugs drop sharply,and makes the logistics and distribution revenue of traditional medicine commercial companies decrease synchronously.These influences continue to ferment in the pharmaceutical circulation industry,forcing pharmaceutical commercial companies to think about the future.Based on the background of two vote policy,this paper takes FY pharmaceutical commercial company as the main research object,uses the theory of modern strategic management and research and analysis methods to carry out extensive and in-depth investigation and Research on FY pharmaceutical commercial company,puts forward the plan of strategic transformation and takes action.The paper is divided into six parts,the first part introduces the research background,significance,research ideas and methods;the second part introduces the related theories and literature review;the third part briefly introduces the company’s business situation,then combines pest theory to study the macro environment of the company,and uses Porter Five Forces Model to analyze the company’s industrial environment,and finally two votes The fourth part discusses the necessity and feasibility of the strategic transformation of the company.Firstly,through internal interviews,it investigates the current development difficulties and analyzes the threats and opportunities faced by the company under the background of two vote system.Secondly,it summarizes the core competitiveness of the company,and finally uses SWOT analysis model to make a comprehensive analysis of the feasibility of the company’s strategic transformation.In the fifth part,combined with BCG matrix analysis model,it is determined that the market development strategy of FY pharmaceutical commercial company should be transferred from city level hospitals to basic medical institutions and the third terminal market,and at the same time,it should carry out pharmaceutical valueadded services up and down the supply chain And develop diversified service products,so as to transform from traditional drug distribution dealers to comprehensive pharmaceutical value-added service providers,and specifically implement the transformation plan and safeguard measures.Finally,the paper compares the operation of the company’s strategic transformation under the background of two vote system;the sixth part summarizes and prospects the full text.Based on the current situation of drug distribution industry in China,this paper focuses on the opportunities and challenges faced by drug distribution enterprises under the background of the full implementation of the two vote system.Under the background of two ticket system,the logistics distribution,distribution allocation and consumer direct sales of the three business segments of traditional pharmaceutical commercial companies are affected to varying degrees.Among them,the distribution allocation business based on multi ticket system will be completely eliminated,the profit level of logistics distribution business will decline,and the income of consumer direct sales business will decline.Under the background of the two vote system,the concentration of the industry has increased dramatically.The survival pressure of small and medium-sized pharmaceutical commercial companies,which were originally rooted in the county and district level primary medical market,has increased,and a large number of them have been eliminated and merged,freeing up a broad primary market,providing a new target for the enterprise market development.For a long time,the pharmaceutical marketing mode of "high pricing,high gross profit and high promotion cost" of pharmaceutical manufacturers has also lost the foundation of multi ticket system of price increase and cash withdrawal layer by layer,which makes manufacturers have to shift the focus of marketing work from "sales with gold" to "academic marketing".At the same time,the survival way of "medical care with medicine" formed by medical institutions for many years has also been forced to change.Medical institutions must return to the foundation of medical treatment,and the pharmaceutical service work will be independent.The practical demand in the upstream and downstream of the industrial chain has created a historical opportunity for pharmaceutical commercial companies to transform from traditional pharmaceutical distribution distributors to comprehensive pharmaceutical service providers.Under the background of the two vote system,how to give full play to the advantages of the past favorable resources,grasp and adapt to the tide of the reform of the medical and health system in the new era,choose the development strategy suitable for yourself,and step into the new track of rapid development,which has certain reference significance for the whole pharmaceutical circulation industry.